Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
# HS600B
All products / Type / Easy Pen Retatrutide 10mg Easy Pen Triple GLP-1/GIP/glucagon agonist weight, glycemic & metabolic research SKU: EP-RET-10-1 Format Easy Pen Dosage 0.05mg per click Capacity 10 mg Potential benefits Weight-reduction research Glycemic-control research Liver-fat & liver-health research Cardiometabolic-marker research Body-composition research Weekly subcutaneous dosing In clinical trials, Retatrutide showed among the highest weight-reduction results recorded in clinical research for a non-surgical agent, while also addressing underlying drivers of metabolic disease
GLP-1 analogues have shown promise in improving cardiovascular health by reducing the risk of heart disease in individuals with obesity and diabetes
They have the same effects on the body as GLP-1 injections because they contain the same active ingredient
Dry mouth by dose: what to expect at each level Tirzepatide dosing follows a predictable escalation pattern
Australian Peptide supplies Retatrutide exclusively as a research material intended for laboratory investigation
